Fidelity Select Portfolios · net assets $3.35B · 59 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 96.6% · EP: 2.2% · STIV: 1.2% · DBT: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $19.4M | $10.6M | $11.1M |
| Reinvestment | $69.1 | $0 | $0 |
| Redemptions | $93.5M | $74.1M | $77.8M |
| Net realized gain (non-derivative) | $7.4M | $25.7M | $48.6M |
| Net unrealized appreciation (non-derivative) | $160M | $91.9M | $242M |
The three months of the reporting period, as filed; month 3 ends August 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Thermo Fisher Scientific Inc EC | $589M | 17.59% |
| Danaher Corp EC | $470M | 14.04% |
| Intuitive Surgical Inc EC | $177M | 5.29% |
| Waters Corp EC | $143M | 4.27% |
| West Pharmaceutical Svcs Inc EC | $136M | 4.08% |
| Agilent Technologies Inc EC | $131M | 3.90% |
| Boston Scientific Corp EC | $129M | 3.85% |
| 10x Genomics Inc EC | $125M | 3.73% |
| Abbott Laboratories EC | $116M | 3.46% |
| Stryker Corp EC | $107M | 3.19% |
| Illumina Inc EC | $107M | 3.19% |
| Edwards Lifesciences Corp EC | $103M | 3.09% |
| Iqvia Holdings Inc EC | $102M | 3.04% |
| Repligen Corp EC | $90.5M | 2.70% |
| Natera Inc EC | $90.1M | 2.69% |
| Sartorius Stedim Biotech EC | $74.7M | 2.23% |
| Guardant Health Inc EC | $63.6M | 1.90% |
| Revvity Inc EC | $49.5M | 1.48% |
| Lifestance Health Group Inc EC | $49.4M | 1.48% |
| Bruker Corp EC | $46.3M | 1.38% |
| Heartflow Inc EC | $42.3M | 1.26% |
| Fidelity Revere Street Trust STIV | $39.2M | 1.17% |
| Minimed Group Inc EC | $37.5M | 1.12% |
| Irhythm Technologies Inc EC | $33.3M | 1.00% |
| Caris Life Sciences Inc EC | $31.7M | 0.95% |
| Veeva Sys Inc EC | $30M | 0.90% |
| Twist Bioscience Corp EC | $27.8M | 0.83% |
| Veracyte Inc EC | $25.9M | 0.77% |
| Kestra Medical Technologies Inc EC | $25.8M | 0.77% |
| 10x Genomics Inc EC | $24.5M | 0.73% |
| Medpace Hldgs Inc EC | $20.8M | 0.62% |
| Shoulder Innovations Inc EC | $19.9M | 0.59% |
| Element Biosciences Inc EP | $19M | 0.57% |
| Medline Inc EC | $15.8M | 0.47% |
| Mettler-toledo Intl Inc EC | $15.2M | 0.45% |
| Kardium Corp EP | $13.3M | 0.40% |
| Kardium Corp EP | $12.3M | 0.37% |
| Ceribell Inc EC | $10.2M | 0.30% |
| Almar Biosciences Inc EC | $8.55M | 0.26% |
| Aledade Inc EP | $6.8M | 0.20% |
| Manus Bio Inc EP | $6.45M | 0.19% |
| Insulet Corp EC | $5.2M | 0.16% |
| Dna Script Sas EP | $3.37M | 0.10% |
| Galvanize Therapeutics EP | $2.73M | 0.08% |
| Galvanize Therapeutics EP | $2.62M | 0.08% |
| Asimov Inc EP | $2.6M | 0.08% |
| Dmed Biopharmaceutical Co Ltd EP | $2.48M | 0.07% |
| Aledade Inc EP | $2.27M | 0.07% |
| Galvanize Therapeutics DBT | $996K | 0.03% |
| Saluda Medical Inc EC | $977K | 0.03% |
| Elevatebio, LLC EP | $395K | 0.01% |
| Conformal Medical Inc EC | $70.8K | 0.00% |
| Conformal Medical Inc EC | $35.4K | 0.00% |
| Dna Script Sas EC | $27.6K | 0.00% |
| Prognomiq Inc EC | $17.8K | 0.00% |
| Dna Script Sas EC | $7.2K | 0.00% |
| Dna Script Sas EP | $475 | 0.00% |
| Conformal Medical Inc EC | $35.4 | 0.00% |
| Saluda Medical Inc EC | — | 0.00% |
Loading...
